We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Amoeba (ALMIB) EUR0.01

Sell:€0.87 Buy:€0.90 Change: €0.019 (2.11%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Sell:€0.87
Buy:€0.90
Change: €0.019 (2.11%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Sell:€0.87
Buy:€0.90
Change: €0.019 (2.11%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Amoeba SA is a France-based company that develops, manufactures and markets biological products. The Company specializes in disruptive biological solutions for the treatment of Legionella, amoeba and biofilm in water. The Company's offering includes products and services, such as: Cleantech biological solution, a patented technological disruptive product with no impact on the environment; amoebic analyses of waters of wet cooling towers (TAR), hot sanitary waters, industrial waters and waters of swimming pools; as well as Legionella tests of industrial waste water, among others. The Company is engaged in various technical, commercial, industrial and investment partnerships.

Contact details

Address:
38 avenue des Freres Montgolfier
CHASSIEU
69680
France
Telephone:
+33 (4) 26691600
Website:
https://amoeba-nature.com/en/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ALMIB
ISIN:
FR0011051598
Market cap:
€43.75 million
Shares in issue:
49.66 million
Sector:
Specialty Chemicals
Exchange:
Euronext Paris
Country:
France
Currency:
Euro
Indices:
n/a

Key personnel

  • Benoit Villers Suisse
    Chairman of the Board
  • Jean-francois Doucet
    Chief Executive Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.